APA način citiranja

Lafayette, R. A., Rovin, B. H., Reich, H. N., Tumlin, J. A., Floege, J., & Barratt, J. (2020). Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy. Kidney Int Rep.

Čikaški stil citiranja

Lafayette, Richard A., Brad H. Rovin, Heather N. Reich, James A. Tumlin, Jürgen Floege, i Jonathan Barratt. "Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy." Kidney Int Rep 2020.

MLA način citiranja

Lafayette, Richard A., et al. "Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy." Kidney Int Rep 2020.